INSM
Insmed (INSM)
$
31About Insmed (INSM)
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
Details
Daily high
$79.41
Daily low
$77.83
Price at open
$78.72
52 Week High
$82.04
52 Week Low
$21.92
Market cap
14.2B
Dividend yield
0.00%
Volume
155
Avg. volume
1.7M
P/E ratio
-14.28
Insmed News
Details
Daily high
$79.41
Daily low
$77.83
Price at open
$78.72
52 Week High
$82.04
52 Week Low
$21.92
Market cap
14.2B
Dividend yield
0.00%
Volume
155
Avg. volume
1.7M
P/E ratio
-14.28